Treatment Modification After Initiating Second-Line Medicati

Among adults with type 2 diabetes who started noninsulin second-line therapy, most modified treatment within 1 year. Discontinuation was by far the most common modification.

Related Keywords

Quebec , Canada , Lake Shore , California , United States , Chicago , Illinois , Northwestern University , Eli Lilly , Endocr Disord , Sanya Pasricha , National Health , Adm , Value Health , American Diabetes Association Scientific Sessions On , Health Aff Millwood , Northwestern University Feinberg School Of Medicine , American College Of Physicians , Nutrition Examination , Study Research Group , Institute For Public Health , Unitedhealth Group , Division Of Endocrinology , Novo Nordisk , Program Collaborative Group , Health Serv Res , Institute Inc , Medicare Advantage , Appendix Figure , Diabetes Complications Severity Index , Appendix Table , Sterling Harris , American Diabetes Association Scientific Sessions , General Internal Medicine , Public Health , Molecular Medicine , Northwestern University Feinberg School , Applied Research , Diabetes Res , Clinical Guidelines Committee , American College , Ann Intern , Complications Severity Index , Metab Syndr , Manag Care Spec , Gen Intern , Diabetes Study , Northern California , Health Serv , Diabetes , T2d , Modification ,